Table 1 Patients with CLL/SLL and histiocytic/dendritic cell neoplasms

From: Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases

Case no.

Age (year)/sex a

Site of CLL/SLL and treatment

Site of H/DC neoplasm

Interval d

1

55/M

Peripheral blood

Cervical LN

10 months

2

62/M

Peripheral blood

Axillary LN

Long term

3

65/M

Peripheral blood, generalized adenopathy, s/p chemotherapy

Cervical LN

3 years

4

71/M

Axillary LN, s/p chemotherapy

Spleen

1 year

5

77/M

Peripheral blood, s/p chemotherapy

Axillary LNb

3 years

6

82/M

Peripheral blood, s/p chemotherapy

Bone marrowc

11 years

7

85/M

Axillary LN

Same specimen

Synchronous

  1. CLL/SLL, chronic lymphocytic leukemia/small lymphocytic lymphoma; H/DC, histiocytic or dendritic cell; s/p, status post; LN, lymph node.
  2. aAge at presentation with histiocytic/dendritic cell neoplasm.
  3. bPatient also had enlarged liver and spleen that were not biopsied.
  4. cPatient also had cervical lymphadenopathy that was not biopsied.
  5. dInterval between the initial diagnosis of CLL/SLL and subsequent H/DC neoplasm.
Back to article page